No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
ARGX240517C350000
- 26.00
- +6.30+31.98%
15min DelayClose May 10 10:27 ET
26.00High26.00Low
26.00Open19.70Pre Close1 Volume7 Open Interest350.00Strike Price2.60KTurnover35.42%IV0.29%PremiumMay 17, 2024Expiry Date24.63Intrinsic Value100Multiplier7DDays to Expiry1.37Time Value100Contract SizeAmericanOptions Type0.9193Delta0.0080Gamma14.58Leverage Ratio-0.2316Theta0.0640Rho13.40Eff Leverage0.0794Vega
Intraday
- 5D
- 1D
News
Argenx SE (NASDAQ:ARGX) Q1 2024 Earnings Call Transcript
Argenx Price Target Cut to $448.00/Share From $451.00 by HC Wainwright & Co.
Argenx Price Target Cut to $448.00/Share From $451.00 by HC Wainwright & Co.
Argenx Is Maintained at Buy by HC Wainwright & Co.
Argenx Is Maintained at Buy by HC Wainwright & Co.
Breaking Down Argenx: 12 Analysts Share Their Views
In the latest quarter, 12 analysts provided ratings for argenx (NASDAQ:ARGX), showcasing a mix of bullish and bearish perspectives.The table below offers a condensed view of their recent ratings, show
Argenx Is Maintained at Market Outperform by JMP Securities
Argenx Is Maintained at Market Outperform by JMP Securities
Express News | JMP Securities Maintains Market Outperform on Argenx, Lowers Price Target to $468
Comments
it's number 4, $Amylyx Pharmaceuticals(AMLX.US$ all time low 6.5 USD... hope you can grow and get all FDA approval... it's profitable already...
no 1. $Biogen(BIIB.US$ all time low 2 USD
no 2. $Neurocrine Biosciences(NBIX.US$ all time low 1.9 USD
no 3. $Biohaven(BHVN.US$ all time low 7 USD
no5. $argenx SE(ARGX.US$ all time low 17 USD
And it's not bubble. Of course there are also, biotech companies which are failed. But I think if it's growing into a right directio...
no 1. $Biogen(BIIB.US$ all time low 2 USD
no 2. $Neurocrine Biosciences(NBIX.US$ all time low 1.9 USD
no 3. $Biohaven(BHVN.US$ all time low 7 USD
no5. $argenx SE(ARGX.US$ all time low 17 USD
And it's not bubble. Of course there are also, biotech companies which are failed. But I think if it's growing into a right directio...
2
$Cellectar BioSciences(CLRB.US$ Phase 2
$Regenxbio(RGNX.US$ Phase 2
$Leap Therapeutics(LPTX.US$ Phase 2
$4D Molecular Therapeutics(FDMT.US$ Phase 2
$Adverum Biotechnologies(ADVM.US$ Phase 2
$Denali Therapeutics(DNLI.US$ Phase 2
$EyePoint Pharmaceuticals(EYPT.US$ Phase 2
$Xencor(XNCR.US$ Phase 2
$Harmony Biosciences(HRMY.US$ Phase 2
$Alnylam Pharmaceuticals(ALNY.US$ Phase 2
$Disc Medicine(IRON.US$ Phase 2
$Atea Pharmaceuticals(AVIR.US$ Phase 2
$Allakos(ALLK.US$ Phase 2...
$Regenxbio(RGNX.US$ Phase 2
$Leap Therapeutics(LPTX.US$ Phase 2
$4D Molecular Therapeutics(FDMT.US$ Phase 2
$Adverum Biotechnologies(ADVM.US$ Phase 2
$Denali Therapeutics(DNLI.US$ Phase 2
$EyePoint Pharmaceuticals(EYPT.US$ Phase 2
$Xencor(XNCR.US$ Phase 2
$Harmony Biosciences(HRMY.US$ Phase 2
$Alnylam Pharmaceuticals(ALNY.US$ Phase 2
$Disc Medicine(IRON.US$ Phase 2
$Atea Pharmaceuticals(AVIR.US$ Phase 2
$Allakos(ALLK.US$ Phase 2...
36
6
$argenx SE(ARGX.US$
Clinical Disappointment in Phase 3 Study: Pemphigus Vulgaris (PV) and Pemphigus Foliaceus (PF)
Argenx's shares nosedived by 25% due to disappointing results from its Phase 3 study on efgartigimod subcutaneous (SC) for treating severe autoimmune diseases. The study aimed to address pemphigus vulgaris (PV) and pemphigus foliaceus (PF), causing skin blistering.
Unexpectedly Strong Impact of Corticosteroids
The primary setback was the ...
Clinical Disappointment in Phase 3 Study: Pemphigus Vulgaris (PV) and Pemphigus Foliaceus (PF)
Argenx's shares nosedived by 25% due to disappointing results from its Phase 3 study on efgartigimod subcutaneous (SC) for treating severe autoimmune diseases. The study aimed to address pemphigus vulgaris (PV) and pemphigus foliaceus (PF), causing skin blistering.
Unexpectedly Strong Impact of Corticosteroids
The primary setback was the ...
2
Read more
72840290 : you dont pump much do you @Nasser09
Jaguar8 72840290:
Jaguar8 72840290: Spotted huh?
NASSER09OP 72840290: I have another App